BioWorld

May 24, 2007

Public Offering Generates $163M In Cash For Advanced Magnetics

Awaiting results from the final of four pivotal studies of its iron replacement therapeutic ferumoxytol, Cambridge, Mass.-based Advanced Magnetics Inc. is raising $162.9 million. (BioWorld Today) Read More

Cypress Shares Soar On Positive Phase III Data In Fibromyalgia

Vion Halts Phase III AML Trial, Causing Stock Drop

NewCo News: Arete Completes $51M Round For New Hypertension Class

Sirtris Increases Shares, Raises $60M In IPO For Sirtuin Work

Pivotal PolyHeme Trial Fails To Hit Endpoints, Hurting Northfield

Other News To Note

U.S. Patent Disclosures

Clinic Roundup

Today's news in brief

BioWorld

BioWorld briefs for June 4, 2026.

ASCO 2026: A revolution in pancreatic cancer

BioWorld

At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...

News in brief

BioWorld Asia

BioWorld Asia briefs for June 2, 2026

EASL 2026: Emerging liver disease targets to watch

BioWorld

At the recently concluded European Association for the Study of the Liver meeting, presentations underscored how increasingly granular insights into liver...

Bispecific antibodies with heavy chain in green and pink, light chain in blue and yellow

ASCO 2026: PD-(L)1 x VEGF bispecifics fight it out

BioWorld

Multiple companies are chasing Akeso Inc. and Summit Therapeutics Inc. in the battle to potentially dethrone Keytruda (pembrolizumab, Merck & Co. Inc.) as the top...